KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 104 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,367,000 | +0.6% | 18,235 | +1.0% | 0.01% | 0.0% |
| Q2 2015 | $1,359,000 | +77.2% | 18,048 | +18.0% | 0.01% | +66.7% |
| Q1 2015 | $767,000 | +61.8% | 15,289 | +11.8% | 0.01% | +100.0% |
| Q4 2014 | $474,000 | +5.8% | 13,675 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $448,000 | -14.7% | 13,675 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $525,000 | +24.7% | 13,675 | +29.1% | 0.00% | +33.3% |
| Q1 2014 | $421,000 | +4.5% | 10,593 | -2.0% | 0.00% | 0.0% |
| Q4 2013 | $403,000 | +1.5% | 10,806 | +24.5% | 0.00% | 0.0% |
| Q3 2013 | $397,000 | +68.9% | 8,679 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $235,000 | – | 8,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |